De Novo device
NTX100 Tonic Motor Activation (NTX100 ToMAc) System
Noctrix Health, Inc. · Stimulator, Nerve, For Restless Legs Syndrome (QWD, Class II) · First FDA decision Apr 17, 2023, newest Apr 17, 2023
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "NTX100 Tonic Motor"
MAUDE reports
0
Brand "NTX100 Tonic Motor", since 2015
PubMed studies
0
Mentioning "NTX100 Tonic Motor"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- NTX100 Tonic Motor Activation (NTX100 ToMAc) SystemNew device typeBreakthroughDe Novo
DEN220059 · Decided Apr 17, 2023 · 208 days after receipt
Device type: Stimulator, Nerve, For Restless Legs Syndrome (QWD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Serum Iron Studies (Addition of Restless Leg Syndrome as a Covered Indication)National analysisReview closedCAG-00263RUpdated Sep 23, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "NTX100 Tonic Motor", any status and sponsor, newest update first.
- A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLSActive, not recruiting
Noctrix Health, Inc.Not on our public-company list
NCT06076499 · 325 participants (planned) · Start Nov 15, 2023 · Primary completion Jul 2026
Device: NTX100 · For: Restless Legs Syndrome
Sites: Downey, California; San Ramon, California; Newton, Massachusetts · 7 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NTX100 Tonic Motor", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QWD
2 reports: 0 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NTX100 Tonic Motor"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.